Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
Randomised study to assess the efficacy and safety of once-daily etravirine-based regimen as a switching strategy in HIV-infected patients receiving a protease inhibitor-containing regimen. Etraswitch study.
Patterns of transmitted HIV drug resistance in Europe vary by risk group.
Decreased phenotypic susceptibility to etravirine in patients with predicted genotypic sensitivity.
Genotypic tropism testing in proviral DNA to guide maraviroc initiation in aviremic subjects: 48-week analysis of the PROTEST study.
2014 Update of the drug resistance mutations in HIV-1.
Highly pathogenic adapted HIV-1 strains limit host immunity and dictate rapid disease progression.
Hepatitis C virus NS3/4A quasispecies diversity in acute hepatitis C infection in HIV-1 co-infected patients.
Plasma HIV-1 tropism and risk of short-term clinical progression to AIDS or death.
Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe.
Adjudicated morbidity and mortality outcomes by age among individuals with HIV infection on suppressive antiretroviral therapy.